Medovate, a dynamic medical device company dedicated to the development and commercialisation of innovative medical technologies, and Vygon Group, a group specialising in single-use medical devices, today announce that they have signed an exclusive deal to distribute SAFIRA® (SAFer Injection for Regional Anaesthesia) across 60 countries.
Medtech Accelerator, the joint funding venture between Health Enterprise East (HEE), Eastern AHSN (Academic Health Science Network), New Anglia Local Enterprise Partners and local councils, has announced its latest award of £125,000 to develop an exciting medical technology which provides a novel approach to cervical screening.
Cambridge-based Ablatus Therapeutics Limited has been awarded £1.4m by the UK government’s Innovate UK to develop its next-generation, minimally-invasive treatment for soft tissue tumours. The award will fund a 2-year project to develop the prototype device into a final version for use in patients for the first time.
Medtech Accelerator, a joint venture between innovation hub Health Enterprise East (HEE), Eastern AHSN (Academic Health Science Network) and regional business partners to support medtech pioneers, has announced an award of £125,000 to Cambridge-based company NeutroCheck, to progress development of an at-home safety monitoring test for chemotherapy patients.
A pioneering endoscopic surgical device, backed by the Medtech Accelerator, has been licensed to medical device company Medovate who will be responsible for bringing it to market. The new device, ENDOVAC, has the potential to dramatically improve survival of patients with life threatening infection following a leak from the upper gastrointestinal (GI) tract whilst significantly enhancing current treatment methods.
The Medtech Accelerator has announced awards totalling £150,000 to support two new clinically-led teams in the fields of critical care logistics and cornea graft replacement surgery.
This September, the week long MedTechBoost will blend PhD & Post-Doc students and startups, combined with key people at EAHSN, and take them through a structured process of practical ideation, venture development, and lean solution-design, to create and develop ground-breaking new solutions for the NHS.
The Medtech Accelerator is pleased to announce awards amounting to more than £430,000 to four new pioneering projects.
Have an idea to improve clinical practice - such as a device, software and eHealth - find out how the Medtech Accelerator can support your innovation by taking a look at our first webinar which took place on the 11th September.
NVM Private Equity (“NVM”) has invested £1.0 million of growth capital into Cambridge-based medical device company Ablatus Therapeutics (“Ablatus”) alongside existing angel investors and the Medtech Accelerator.
Medtech Accelerator are pleased to announce details of the latest Health Hack - Patient Safety. Taking place on Thursday 3rd & Friday 4th May 2018 at the Anglia Ruskin University Campus, Chelmsford, we are keen to build on the success of previous Hackathons.
Accelerator also receives new £500k investment from Essex County Council...
Medtech Accelerator, a joint venture with innovation hub Health Enterprise East (HEE), has unveiled its latest round of successfully funded projects, with financial awards totalling nearly half a million pounds.
Supported by Marks & Clerk LLP and Jaltek Systems, Medtech Accelerator are pleased to announce details of the next Health Hack - Surgery. Taking place on Thursday 18th & Friday 19th January 2018 at the Cambridge Science Park we are keen to build on the success of the first Hackathon - Rehabilitation Technology.
Uncovering the latest innovative healthcare technology with the first Medtech Accelerator Health Hack.
The Medtech Accelerator, a new company set up to provide proof of concept financial awards to support development of medical technology and software innovations originating primarily from within the NHS, today announced the first round of successful projects. Three pioneering projects will share in £200K to help progress their early stage technologies towards viable solutions to currently unmet healthcare needs.